Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 6/20 | 0.53 |
| ▸ | ADH1A | P07327 | 6/20 | 0.53 |
| ▸ | ADH7 | P40394 | 5/20 | 0.53 |
| ▸ | ADH1C | P00326 | 5/20 | 0.48 |
| ▸ | ADH4 | P08319 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27894065 | 1.00 | — | — | |
| SCHEMBL26448 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1060688 | 0.93 | — | — | |
| SCHEMBL4209237 | 0.93 | ADH1B (0.53) | ADH1BADH1AADH7ADH1CADH4 | |
| SCHEMBL724338 | 0.93 | — | — | |
| SCHEMBL6057638 | 0.87 | — | — | |
| Ethylamine SCHEMBL11633796 | 0.87 | — | — | |
| SCHEMBL27470427 | 0.84 | — | — | |
| Dimethylformamide SCHEMBL10481217 | 0.82 | TSHR (0.50) | ADH1BADH1AADH7ADH1CADH4 | |
| Sulfuric Acid SCHEMBL11476763 | 0.82 | ADH1B (0.50) | ADH1BADH1AADH7ADH1CADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090030-A1 | COMPOSITE OXIDE SEMICONDUCTOR AND TRANSISTOR | SEMICONDUCTOR ENERGY LAB (JP) | 2026-03-26 | — | — | US | disclosed |
| US-20260020289-A1 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20260006767-A1 | SEMICONDUCTOR DEVICE, MEMORY DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2026-01-01 | — | — | US | disclosed |
| US-12482415-B2 | Display apparatus and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20250301707-A1 | OXIDE SEMICONDUCTOR FILM AND SEMICONDUCTOR DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250159941-A1 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF | SEMICONDUCTOR ENERGY LAB (JP) | 2025-05-15 | — | — | US | disclosed |
| US-20250130659-A1 | INPUT DEVICE, INPUT/OUTPUT DEVICE, AND DATA PROCESSING DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20250126795-A1 | SEMICONDUCTOR DEVICE, STORAGE DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2025-04-17 | — | — | US | disclosed |
| US-20250081536-A1 | SEMICONDUCTOR DEVICE, MANUFACTURING METHOD OF THE SEMICONDUCTOR DEVICE, OR DISPLAY DEVICE INCLUDING THE SEMICONDUCTOR DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2025-03-06 | — | — | US | disclosed |
| US-20250081619-A1 | DISPLAY DEVICE AND METHOD FOR MANUFACTURING DISPLAY DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2025-03-06 | — | — | US | disclosed |
| US-20160322504-A1 | SEMICONDUCTOR DEVICE, DRIVER CIRCUIT, AND DISPLAY DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20150144946-A1 | DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2015-05-28 | — | — | US | disclosed |
| US-20150108474-A1 | Display Device | SEMICONDUCTOR ENERGY LABORATORY CO. , LTD. (JP) | 2015-04-23 | — | — | US | disclosed |
| US-9006088-B2 | Method for forming semiconductor gate structure and semiconductor gate structure | TSINGHUA UNIVERSITY (CN) | 2015-04-14 | — | — | US | disclosed |
| WO-2014161231-A1 | METHOD FOR FORMING SEMICONDUCTOR GATE STRUCTURE AND SEMICONDUCTOR GATE STRUCTURE | TSINGHUA UNIVERSITY (CN) | 2014-10-09 | — | — | WO | disclosed |
| US-20140291727-A1 | METHOD FOR FORMING SEMICONDUCTOR GATE STRUCTURE AND SEMICONDUCTOR GATE STRUCTURE | TSINGHUA UNIVERSITY (CN) | 2014-10-02 | — | — | US | disclosed |
| WO-2014133176-A1 | SEMICONDUCTOR DEVICE, DRIVER CIRCUIT, AND DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-04 | — | — | WO | disclosed |
| WO-2014065389-A1 | CENTRAL CONTROL SYSTEM | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-01 | — | — | WO | disclosed |
| US-7569575-B2 | Formed via intermediates which are reactive with nucleophiles | SANTARIS PHARMA A/S (DK) | 2009-08-04 | — | — | US | disclosed |
| US-20040014959-A1 | Synthesis of locked nucleic acid derivatives | SANTARIS PHARMA A/S (DK) | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014959-A1 | Synthesis of locked nucleic acid derivatives | NSUN3, RNGTT, NSUN2 | ADH1B 1240/4885ADH1A 2373/4885ADH7 1974/4885 |
| US-20260020289-A1 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | GJB2, ITK, SCNN1B | ADH1B 3208/4885ADH1A 3837/4885ADH7 3166/4885 |
| US-20260006767-A1 | SEMICONDUCTOR DEVICE, MEMORY DEVICE, AND ELECTRONIC DEVICE | ORAI2, ICOSLG, PIEZO1 | ADH1B 4418/4885ADH1A 3206/4885ADH7 3883/4885 |
| US-20260090030-A1 | COMPOSITE OXIDE SEMICONDUCTOR AND TRANSISTOR | ZKSCAN2, PYM1, ZYX | ADH1B 3114/4885ADH1A 1900/4885ADH7 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.